Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model

Archives of Gynecology and Obstetrics

Volumn 292, Issue 5, 2015, Pages 1145-1152

  Ashrafi, Mahnaz ^a,b   Bahmanabadi, Akram ^a   Akhond, Mohammad Reza ^a   Arabipoor, Arezoo ^a  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Non polycystic ovarian syndrome; OHSS; Risk factors; Statistical model

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL;

ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL EVALUATION; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; HYPOTHYROIDISM; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; NON POLYCYSTIC OVARIAN SYNDROME; OVARY DISEASE; OVARY HYPERSTIMULATION; PREDICTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; CHEMICALLY INDUCED; EVALUATION STUDY; INFERTILITY; MIDDLE AGED; OVARIAN HYPERSTIMULATION SYNDROME; OVARY FOLLICLE; OVULATION INDUCTION; PATHOLOGY; POLYCYSTIC OVARY SYNDROME; PROCEDURES; REGRESSION ANALYSIS; STATISTICAL MODEL;

ADULT; CHORIONIC GONADOTROPIN; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY; MIDDLE AGED; MODELS, STATISTICAL; OVARIAN FOLLICLE; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 84942980389     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-015-3723-0     Document Type: Article

References (28)

1. Kumar P, Sait SF, Sharma A, Kumar M (2011) Ovarian hyperstimulation syndrome. J Hum Reprod Sci. 4(2):70–75 Epub 2011/11/09
2. Delvigne A, Rozenberg S (2002) Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 8(6):559–577 Epub 2002/12/25
3. Alper MM, Smith LP, Sills ES (2009) Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management. J Exp Clin Assist Reprod 6:3 Epub 2009/01/01
4. Papanikolaou EG, Humaidan P, Polyzos NP, Tarlatzis B (2010) Identification of the high-risk patient for ovarian hyperstimulation syndrome. Semin Reprod Med 28(6):458–462 Epub 2010/11/18
5. Papanikolaou EG, Humaidan P, Polyzos N, Kalantaridou S, Kol S, Benadiva C et al (2011) New algorithm for OHSS prevention. Reprod Biol Endocrinol 9:147 Epub 2011/11/08
6. Nastri CO, Ferriani RA, Rocha IA, Martins WP (2010) Ovarian hyperstimulation syndrome: pathophysiology and prevention. J Assist Reprod Genet 27(2–3):121–128 Epub 2010/02/09
7. Fiedler K, Ezcurra D (2012) Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol 10(1):32 Epub 2012/04/26
8. Ovarian Kasum M (2004) Ovarian hyperstimulation syndrome. Gynaecol Perinatol 13(2):62–68
9. Ovarian hyperstimulation syndrome (2008) Fertil Steril 90(5 Suppl):S188–S193 Epub 2008/11/26
10. Moos J, Rezabek K, Filova V, Moosova M, Pavelkova J, Peknicova J (2009) Comparison of follicular fluid and serum levels of Inhibin A and Inhibin B with calculated indices used as predictive markers of Ovarian Hyperstimulation Syndrome in IVF patients. Reprod Biol Endocrinol 7:86 Epub 2009/08/26
11. Lee TH, Liu CH, Huang CC, Wu YL, Shih YT, Ho HN et al (2008) Serum anti-Mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod 23(1):160–167 Epub 2007/11/15
12. Oyesanya OA, Parsons JH, Collins WP, Campbell S (1995) Total ovarian volume before human chorionic gonadotrophin administration for ovulation induction may predict the hyperstimulation syndrome. Hum Reprod 10(12):3211–3212 Epub 1995/12/01
13. Binder H, Flegel WA, Emran J, Muller A, Cupisti S, Beckmann MW et al (2008) Blood group A: an overseen risk factor for early-onset ovarian hyperstimulation syndrome? Reprod Biomed Online 17(2):185–189 Epub 2008/08/07
14. Rajesh H, Lee WY, Fook-Chong S, Yu SL (2011) Ovarian hyperstimulation syndrome: an analysis of patient characteristics in the Asian population. Singapore Med J 52(3):168–174 Epub 2011/04/01
15. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19–25. Epub 2004/01/09
16. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R et al (2011) Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21(10):1081–1125 Epub 2011/07/27
17. Navot D, Relou A, Birkenfeld A, Rabinowitz R, Brzezinski A, Margalioth EJ (1988) Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol 159(1):210–215 Epub 1988/07/01
18. Lyons CA, Wheeler CA, Frishman GN, Hackett RJ, Seifer DB, Haning RV Jr (1994) Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod 9(5):792–799 Epub 1994/05/01
19. Enskog A, Henriksson M, Unander M, Nilsson L, Brannstrom M (1999) Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 71(5):808–814 Epub 1999/05/07
20. Taher BM, Ghariabeh RA, Jarrah NS, Hadidy AM, Radaideh AM, Ajlouni KM (2004) Spontaneous ovarian hyperstimulation syndrome caused by hypothyroidism in an adult. Eur J Obstet Gynecol Reprod Biol 112(1):107–109 Epub 2003/12/23
21. Guvenal F, Guvenal T, Timuroglu Y, Timuroglu T, Cetin M (2006) Spontaneous ovarian hyperstimulation-like reaction caused by primary hypothyroidism. Acta Obstet Gynecol Scand 85(1):124–125 Epub 2006/03/09
22. Edwards-Silva RN, Han CS, Hoang Y, Kao LC (2008) Spontaneous ovarian hyperstimulation in a naturally conceived pregnancy with uncontrolled hypothyroidism. Obstet Gynecol 111(2 Pt 2):498–501 Epub 2008/02/02
23. Rotmensch S, Scommegna A (1989) Spontaneous ovarian hyperstimulation syndrome associated with hypothyroidism. Am J Obstet Gynecol 160(5 Pt 1):1220–1222 Epub 1989/05/01
24. Cardoso CG, Graca LM, Dias T, Clode N, Soares L (1999) Spontaneous ovarian hyperstimulation and primary hypothyroidism with a naturally conceived pregnancy. Obstet Gynecol 93(5 Pt 2):809–811 Epub 2000/07/27
25. Bellver J, Ferrando M, Garrido N, Pellicer A (2010) Blood group and ovarian hyperstimulation syndrome. Fertil Steril 93(1):270–271 Epub 2009/08/18
26. Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S (2011) Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a “freeze-all” strategy: a prospective multicentric study. Fertil Steril 95(6):2029–2033 Epub 2011/03/05
27. Papanikolaou EG, Tournaye H, Verpoest W, Camus M, Vernaeve V, Van Steirteghem A et al (2005) Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod 20(3):636–641 Epub 2004/12/04
28. Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM et al (2006) Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril 85(1):112–120 Epub 2006/01/18